Scarica l'app Stockscreener
197.93
2.17%
4.21
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DHR Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Danaher Corp Borsa (DHR) Ultime notizie
Danaher Corp. focuses on diversified science tools as investors weigh long term growth - AD HOC NEWS
Danaher Corp adjusts guidance after Masimo deal. Analysts highlight cautious upside for the stock - AD HOC NEWS
Spatial Genomics and Transcriptomics Market Size to Reach USD 1.90 Billion by 2035, Growing at a 12.23% CAGR | SNS Insider - GlobeNewswire Inc.
DHRDanaher Corp Latest SEC Filings - Finviz
Deals tracker: Select Medical Holdings acquisition moves forward - Modern Healthcare
Danaher Corp. stock underperforms Monday when compared to competitors - MarketWatch
$1M Danaher grant targets Ebola outbreak in Congo, Uganda - Stock Titan
Danaher (DHR) Completes $9.9B Acquisition of Masimo Corporation - Insider Monkey
Is Danaher (DHR) One of the Best Non-Tech Stocks to Buy According to Analysts? - Insider Monkey
Danaher schedules Q2 earnings call, analysts reassess the shares - Ad-hoc-news.de
Danaher schedules Q2 earnings call, shares steady in S&P 500 - Ad-hoc-news.de
Danaher Corp. stock outperforms competitors on strong trading day - MarketWatch
Danaher boosts product portfolio with the acquisition of Masimo - MSN
Danaher clears new AI milestone with Masimo, shares react on NYSE - Ad-hoc-news.de
Danaher Corp Shs Unsponsored Brazilian Depository Receipt Repr 0.035714285 Sh - TradingView
Danaher Corp. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
DHR Forecast — Price Target — Prediction for 2027 - TradingView
Danaher (DHR) Stock Weighs Mixed Valuation Signals After Recent Price Rebound - Yahoo Finance
Why Danaher (DHR) Stock Rose Today - Quiver Quantitative
Danaher clears FDA hurdle with Masimo, shares extend rebound on NYSE - Ad-hoc-news.de
Danaher (DHR) Crossed Above the 20-Day Moving Average: What That Means for Investors - Yahoo Finance
Why Is (NYSE:DHR) Back in Focus Following AI Monitoring Approval? - Kalkine Media
Danaher $172.5 Million Securities Class Action Settlement - Claim Depot
Is Danaher (DHR) Using Masimo’s New FDA-Cleared AI Tool To Redefine Its Medtech Edge? - Yahoo Finance
A Look at Danaher Corp (DHR) After 5.5% Gain -- GF Value $236.97 vs Price $188.87 - GuruFocus
Danaher Corp Stock (DHR) Moved Up by 4.91% on Jun 24: What Investors Need To Know - TradingKey
HSBC Cuts PT on Danaher Corporation (DHR) – Here’s Why - Insider Monkey
How FDA Clearance of AI Opioid-Respiratory Monitoring Could Shape Danaher’s (DHR) Clinical Data Advantage - simplywall.st
Danaher achieves FDA clearance for Masimo feature, shares steady on NYSE - Ad-hoc-news.de
Danaher Corp (DHR) Institutional Confidence - TradingKey
Danaher plans July 21 earnings call, slide deck at 6 a.m. ET - Stock Titan
Danaher Finalizes $9.9B Purchase of Masimo - Orange County Business Journal
Danaher (DHR) Achieves FDA Clearance for Wearable Monitoring Tec - GuruFocus
Danaher Schedules Second Quarter 2026 Earnings Conference Call - Yahoo Finance
Danaher Stockweekly outlook with earnings and events ahead - Ad-hoc-news.de
Medtech business update: Spectrum Vascular acquires Piccolo Medical, Danaher acquires Masimo - Today's Medical Developments
From bench chaos to calm order, Cytiva ÄKTA pure quietly cleans up protein prep - AD HOC NEWS
Lodi's largest private employer expands with fifth building - The Business Journals
Danaher Corp (DHR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Danaher Corp (DHR) Valuation: PE, PB & Fair Value Analysis - TradingKey
Danaher Corp (DHR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Danaher Corp (DHR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Danaher Corp. stock outperforms competitors despite losses on the day - MarketWatch
Danaher Corp (DHR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Danaher Corp (DHR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Danaher Corp (DHR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
IDBS and Alchemi partner to accelerate biopharma regulatory filings with compliant AI agents - PR Newswire
Danaher’s Cepheid Ebola Tests Highlight Diagnostics Role In Global Crises - Yahoo! Finance Canada
Masimo CEO stepping down following acquisition by Danaher - Modern Healthcare
Danaher Corporation’s (DHR) Recovery Fell Short of Investor Expectations - Yahoo Finance
1.97%
2.02%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):